dc.contributor.author | Bershteyn, Anna | |
dc.contributor.author | Crespo, Monica P. | |
dc.contributor.author | Hanson, Melissa Catherine | |
dc.contributor.author | Irvine, Darrell J | |
dc.date.accessioned | 2015-06-22T13:04:11Z | |
dc.date.available | 2015-06-22T13:04:11Z | |
dc.date.issued | 2014-06 | |
dc.date.submitted | 2014-05 | |
dc.identifier.issn | 1525-7797 | |
dc.identifier.issn | 1526-4602 | |
dc.identifier.uri | http://hdl.handle.net/1721.1/97484 | |
dc.description.abstract | Lipid-coated poly(lactide-co-glycolide) microparticles (LCMPs) consist of a solid polymer core wrapped by a surface lipid bilayer. Previous studies demonstrated that immunization with LCMPs surface-decorated with nanograms of antigen elicit potent humoral immune responses in mice. However, the mechanism of action for these vaccines remained unclear, as LCMPs are too large to drain efficiently to lymph nodes from the vaccination site. Here, we characterized the stability of the lipid envelope of LCMPs and discovered that in the presence of serum the lipid coating of the particles spontaneously delaminates, shedding antigen-displaying vesicles. Lipid delamination generated 180 nm liposomes in a temperature- and lipid/serum-dependent manner. Vesicle shedding was restricted by inclusion of high-T[subscript M] lipids or cholesterol in the LCMP coating. Administration of LCMPs bearing stabilized lipid envelopes generated weaker antibody responses than those of shedding-competent LCMPs, suggesting that in situ release of antigen-loaded vesicles plays a key role in the remarkable potency of LCMPs as vaccine adjuvants. | en_US |
dc.description.sponsorship | National Institutes of Health (U.S.) (AI091693) | en_US |
dc.description.sponsorship | Bill & Melinda Gates Foundation | en_US |
dc.description.sponsorship | Ragon Institute of MGH, MIT and Harvard | en_US |
dc.language.iso | en_US | |
dc.publisher | American Chemical Society (ACS) | en_US |
dc.relation.isversionof | http://dx.doi.org/10.1021/bm500337r | en_US |
dc.rights | Article is made available in accordance with the publisher's policy and may be subject to US copyright law. Please refer to the publisher's site for terms of use. | en_US |
dc.source | American Chemical Society | en_US |
dc.title | Antigen Delivery by Lipid-Enveloped PLGA Microparticle Vaccines Mediated by in Situ Vesicle Shedding | en_US |
dc.type | Article | en_US |
dc.identifier.citation | Hanson, Melissa C., Anna Bershteyn, Monica P. Crespo, and Darrell J. Irvine. “Antigen Delivery by Lipid-Enveloped PLGA Microparticle Vaccines Mediated by in Situ Vesicle Shedding.” Biomacromolecules 15, no. 7 (July 14, 2014): 2475–2481. © 2014 American Chemical Society | en_US |
dc.contributor.department | Harvard University--MIT Division of Health Sciences and Technology | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Biological Engineering | en_US |
dc.contributor.department | Massachusetts Institute of Technology. Department of Materials Science and Engineering | en_US |
dc.contributor.department | Ragon Institute of MGH, MIT and Harvard | en_US |
dc.contributor.department | Koch Institute for Integrative Cancer Research at MIT | en_US |
dc.contributor.mitauthor | Hanson, Melissa C. | en_US |
dc.contributor.mitauthor | Bershteyn, Anna | en_US |
dc.contributor.mitauthor | Crespo, Monica P. | en_US |
dc.contributor.mitauthor | Irvine, Darrell J. | en_US |
dc.relation.journal | Biomacromolecules | en_US |
dc.eprint.version | Final published version | en_US |
dc.type.uri | http://purl.org/eprint/type/JournalArticle | en_US |
eprint.status | http://purl.org/eprint/status/PeerReviewed | en_US |
dspace.orderedauthors | Hanson, Melissa C.; Bershteyn, Anna; Crespo, Monica P.; Irvine, Darrell J. | en_US |
mit.license | PUBLISHER_POLICY | en_US |
mit.metadata.status | Complete | |